O-39 HER2 positive early breast cancers: What proportion...

European Journal of Cancer Supplements 2010 Vol. 8; Iss. 6

O-39 HER2 positive early breast cancers: What proportion are receiving adjuvant Trastuzumab therapy? A multicentre audit

S. Marla, J. Cardale, D.J. Dodwell, A.I. Skene, O. Gojis, P. Abram, C. Palmieri, S.J. Cleator, A. Bowman, J.C. Doughty
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Year:
2010
Language:
english
DOI:
10.1016/j.ejcsup.2010.06.040
File:
PDF, 42 KB
english, 2010
Conversion to is in progress
Conversion to is failed